Detailseite
Projekt Druckansicht

Synthese P-chiraler Phosphane ausgehend von niedrig koordinierten Phosphorverbindungen als bidentate Liganden in der stereoselektiven Katalyse

Antragstellerinnen / Antragsteller Professorin Dr. Evamarie Hey-Hawkins; Professor Dr. Johannes Gerardus de Vries, seit 2/2021
Fachliche Zuordnung Anorganische Molekülchemie - Synthese, Charakterisierung
Förderung Förderung von 2018 bis 2023
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 411421782
 
Erstellungsjahr 2024

Zusammenfassung der Projektergebnisse

Some chemical compounds can exist in two mirror images called enantiomers. This is called chirality. Their chemical properties of enantiomers are the same but in their interaction with biological systems such as enzymes and receptors, which are also chiral, the two enantiomers will behave differently. For that reason, it is important that pharmaceuticals are prepared as single enantiomers. In the past this was done by a cumbersome separation of racemates (the 50/50 mixtures of the two enantiomers), but it is of course much better to immediately synthesise only a single enantiomer. For this, enantioselective catalysis is a highly efficient methodology. The problem is that there are no catalysts that work for all known reactions. The catalysts are organometallic complexes that consist of a transition metal and one or more ligands. The catalyst diversity is largely created by the chiral ligand and hence the synthesis of new classes of ligands is extremely useful as it enlarges the pool of catalysts that can be chosen from. In this project two classes of ligands were investigated. Ligands based on phosphanorbornanes did not induce sufficient selectivity to the products and hence a new class of ligands called diphosphazanes was developed. These ligands were highly successful in enantioselective hydrogenation reactions leading to enantiopure intermediates for pharmaceuticals. In the third part of this research it was successfully attempted to replace the expensive transition metals such as rhodium, iridium and ruthenium by cobalt. Also, with these cobalt-based catalyst it was possible to prepare a series of pharma intermediates.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung